title: Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Lefèvre
authors.forename: Dominique
authors.initials: D
authors.lastname: Dufour
authors.forename: Beatrice
authors.initials: B
authors.lastname: Gulbis
authors.forename: Phu-Quoc
authors.initials: PQ
authors.lastname: Lê
authors.forename: Catherine
authors.initials: C
authors.lastname: Heijmans
authors.forename: Alina
authors.initials: A
authors.lastname: Ferster
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000628:therapy; D000986:Antisickling Agents / Q000008:administration & dosage*; D001783:Blood Flow Velocity / Q000187:drug effects*; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D008297:Male; D020714:Maximum Tolerated Dose; D020768:Middle Cerebral Artery / Q000000981:diagnostic imaging; D011446:Prospective Studies; D020521:Stroke / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D017585:Ultrasonography, Doppler, Transcranial
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea